Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 disease.
Matthew E WitekChristopher G MorrisGregory S AlexanderPragnya DontuAntony I KoroulakisWilliam F RegineWilliam M MendenhallPublished in: Head & neck (2023)
Favorable regional control is achievable with definitive chemoradiation therapy for patients with HNSCC N3 disease. Distant metastases are a common pattern of failure and should be a focus of prospective study.